Peritherapeutic Serum p53 Antibody Titers are Predictors of Survival in Patients with Esophageal Squamous Cell Carcinoma Undergoing Neoadjuvant Chemotherapy and Surgery-Reference-Cited by-同舟云学术

Peritherapeutic Serum p53 Antibody Titers are Predictors of Survival in Patients with Esophageal Squamous Cell Carcinoma Undergoing Neoadjuvant Chemotherapy and Surgery

Published:2017-01-20 Issue:6 Volume:41 Page:1566-1574
ISSN:0364-2313
Container-title:World Journal of Surgery
language:en
Short-container-title:World J Surg

Author:

Yamashita Kotaro,Makino Tomoki,Tanaka Koji,Yamasaki Makoto,Yamamoto Masaaki,Miyazaki Yasuhiro,Takahashi Tsuyoshi,Kurokawa Yukinori,Nakajima Kiyokazu,Takiguchi Shuji,Mori Masaki,Doki Yuichiro

Publisher

Springer Science and Business Media LLC

Subject

Surgery

Link

http://link.springer.com/article/10.1007/s00268-017-3894-x/fulltext.html

Reference20 articles.

1. Lane DP (1992) Cancer. p53, guardian of the genome. Nature 358:15–16

2. Harris CC, Hollstein M (1993) Clinical implications of the p53 tumor-suppressor gene. N Engl J Med 329:1318–1327

3. Greenblatt MS, Bennett WP, Hollstein M et al (1994) Mutations in the p53 tumor suppressor gene: clues to cancer etiology and molecular pathogenesis. Cancer Res 54:4855–4878

4. Yamasaki M, Miyata H, Fujiwara Y et al (2010) p53 genotype predicts response to chemotherapy in patients with squamous cell carcinoma of the esophagus. Ann Surg Oncol 17:634–642

5. Makino T, Yamasaki M, Miyata H et al (2010) p53 Mutation status predicts pathological response to chemoradiotherapy in locally advanced esophageal cancer. Ann Surg Oncol 17:804–811

Cited by 9 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Clinical practice guidelines for molecular tumor marker, 2nd edition review part 2;International Journal of Clinical Oncology;2024-03-17

2. Comparison between a new assay system, Elecsys® Anti‑p53, and conventional MESACUP™ for the detection of serum anti‑p53 antibodies: A multi‑institutional study;Molecular and Clinical Oncology;2022-06-22

3. Assessment of Tumour Response to Neoadjuvant Therapy for the Treatment of Oesophageal Cancer;GI Surgery Annual;2022

4. New Assay System Elecsys Anti-p53 to Detect Serum Anti-p53 Antibodies in Esophageal Cancer Patients and Colorectal Cancer Patients: Multi-institutional Study;Annals of Surgical Oncology;2020-11-18

5. Clinical impact of preoperative serum p53 antibody titers in 1487 patients with surgically treated esophageal squamous cell carcinoma: a multi-institutional study;Esophagus;2020-07-26